You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsInformation about Individual Stocks

Vigonvita Life Sciences Co., Ltd. (02630)

Suzhou Wangshan Wangshui Biomedical Co., Ltd.(referred to as "Wangshan Wangshui") was established in 2013. It is a comprehensive and integrated biomedical company committed to the discovery, development and commercialization of innovative small molecule drugs. The company is committed to meeting clinical needs in the fields of viral infection, neuropsychiatric and reproductive health. The company's founder team is from